Fujifilm Healthcare Europe’s Post

❔ Is Access a role or a goal? We at #teamdecisive believe it is a goal for all functions in organisations we work with to accelerate and innovate on the path to faster, broader patient access around the world. 🤝🏼Medical Affairs has always been a central partner to Market Access in ensuring strategies and plans are well aligned with clinical reality, articulating unmet need, appropriate positioning of a new therapeutic option, and clear explanation of the evidence base all being central to a great submission. Medical Leaders are also often a present voice in HTA committees, and in meetings with Pricing and Reimbursement authorities, playing a strong role in negotiations on the value of a new technology. Relationships with the wider clinical community, and with patient advocacy organisations ensure Medical Affairs leaders enable all voices to be heard through any HTA or P&R process. 🎇So, in our #rebel Decisive way of thinking about this – we believe that there is tremendous strength in Medical Affairs, HEOR and Market Access partnering early in lifecycle to elevate the future needs for successful patient access, and championing together what this means for evidence generation and engagement long before launch. ✨It’s with this in mind that we are delighted to welcome Kevin Asher to #teamdecisive as an Associate. Kevin has worked in Medical Affairs Leadership roles locally, regionally and globally and has a strong appreciation of the role of a great medical affairs function, including the importance of cross-functional engagement at all stages of development. Coupled with his General Management experience in Italy, and a variety of roles focused on transformation of capabilities and structures he brings a different #rebelthinkers lens to the table. 🧩One of the initial areas of focus for Kevin will be around the complex transformations of workflows and interactions surrounding the introduction of Joint Clinical Assessment (JCA) in Europe. Something that all functions need to understand and evolve with if you plan to bring new products to EU markets. He will also be strengthening our offerings in the adjacencies to our existing Access deliverables – including strategic scientific communications, early scientific advice and the elevation of skills and capabilities for Medical Affairs leaders to engage in #allthingsaccess. Please join us in welcoming Kevin to the team. We look forward to the huge impact that we know he’ll have. Bringing more #rebelthinkers to Access - #teamdecisive powering your success. #marketaccess #heor #medicalaffairs #pricing #JCA #HTA

The 2024 Medical Affairs Professional Society (MAPS) Affairs Professional Society Meeting was an incredible gathering of industry leaders, innovators, and experts dedicated to advancing healthcare excellence. Here are some highlights from this impactful event: 🔬 Cutting-Edge Talent: The meeting showcased top talent in medical affairs, highlighting individuals with a passion for driving innovation and improving patient outcomes across the clinical development and medical affairs spectrum. As a leading talent agency, we're committed to connecting clients with exceptional candidates who can make a real difference in healthcare. What better place to meet top talent than MAPS. 🤝 Networking Opportunities: Our team was delighted to participate in networking sessions, connecting with industry leaders and talented professionals alike. These interactions allow us to better understand the evolving needs of our biopharma and candidates alike, ensuring successful matches that drive organizational success. 💼 Strategic Insights: From evidence generation best practices to emerging trends in AI, the meeting provided invaluable insights into the ever-changing landscape of medical affairs. Have no fear, AI is here to stay, but personal insights are also important in medical affairs! 👩⚕️ Elevating Healthcare Together: Ultimately, the 2024 Medical Affairs Professional Society Meeting reaffirmed our shared commitment to excellence in healthcare. By partnering with Mix Talent, companies gain access to the talent and expertise needed to drive innovation, improve patient care, and make a lasting impact. If you're seeking top talent or exploring new career opportunities in medical affairs, we're here to help. Reach out Mix Talent today! And, thank you to all who contributed to the success of this event. Let's continue to work together towards a healthier, brighter future! Great to meeting new folks and seeing familiar faces: Kate Pietrovito Chirag Ghai Akarsh Sakalaspur Gregory Christopherson Danie du Plessis Keith Morris K A Donna Holder Erin Willard Anke Beselin Greg Nowicki Margaret Levy Deborah Ebert Long MD #MedicalAffairs #HealthcareRecruitment #TalentAcquisition #Networking #StrategicHiring #MixTalent

Healthcare opportunities in Germany

There is a lot of excitement happening in the world of Medical Affairs right now! Check out Paige Nelson's key takeaways from the Medical Affairs Professional Society (MAPS) Annual Meeting last week ⬇ #medicalaffairs #trends #lifesciences #healthcare #biotech #msl #AI

The Medical Affairs Role Transformed as Real-World Data Requirements Unfold The transformation of the Medical Affairs function in the healthcare industry has been a popular topic over the past decade. Medical Affairs is indisputably a ‘strategic pillar’ throughout the product lifecycle, and recent needed updates within the healthcare environment have pushed this transformation even further into the world of patient-centricity. The impact on the Medical Affairs profession is pronounced as patient centricity is its mission and practitioners are most often responsible for incorporating non-registrational real world data (RWD), including development of an RWE strategy, into an overarching evidence generation plan to ensure that patient safety and product efficacy are balanced. In this article, the authors will review the scope and emerging importance of RWE, the responsibility of Medical Affairs in the RWE strategy and layout the three key steps to developing a RWE roadmap. If you have experience in Medical Communications/Affairs and are looking for the next step in your career, reach out to me to explore new opportunities. #medicalaffairs #medicalcommunications IQVIA #patientcentricty #realworld Erica Cave, PhD, CMPP Andy Graves Simonetta Santana Jason Murray

💡 Navigating the MSL Landscape: Insights for Aspiring Professionals The journey to becoming a Medical Science Liaison (MSL) is often driven by a passion for bridging the gap between clinical developments and real-world medical practice. For those of us aspiring to enter this esteemed field, understanding the nuances of the role is crucial. Recently, I had the privilege of engaging in a conversation with an experienced MSL, aiming to glean insights into what makes the role both challenging and rewarding. 💡 The Respect for Time: A Testament to Professional Etiquette A fascinating aspect of the MSL role is the culture of respecting each other’s time. In an environment where urgency is a constant, distinguishing between what needs immediate attention and what can wait becomes paramount. The practice of avoiding non-critical communication, especially towards the end of the week, is not just about convenience; it reflects a deeper understanding and respect for the personal and professional boundaries of colleagues. For an aspiring MSL, this insight is invaluable. It teaches the importance of empathy and respect in professional interactions, qualities that are as important as scientific expertise. 💡 The MSL Journey: A Balance of Knowledge and Empathy The conversation shed light on the MSL journey as one that requires balancing a rigorous scientific understanding with the soft skills of empathy, respect, and communication. It’s about being proactive, but also knowing when to pause, listen, and respect the time and efforts of others. This balance is what enables MSLs to build strong, trusted relationships with healthcare professionals, ultimately impacting patient care and medical advancements. #MedicalScienceLiaison #MedicalAffairs #Pharma

I want to say a massive 'thank you' to those of you who have already contributed to the One MSL Global Survey 2024! We've had a fantastic response so far. With your continued support, we can share our most representative data set when the new results go live at the end of March. If you are a #MSL, MSL manager or Medical leader, and are still yet to share your experience, we would love to hear your perspective.   We’re asking colleagues in medical functions worldwide to tell us: how were the past 12 months for you?    Click the link below to complete the survey now:  https://lnkd.in/eajXCD26    Since our first survey in 2018 we have gathered insights from Medical Affairs colleagues in over 70 countries, which helps inform us and the industry alike. You can explore our previous years’ findings in our One Community (https://lnkd.in/gah4sSh).    #fieldmedical #medicalaffairs #survey #research #pharma 

So important to gather data on the medical affairs function - once we understand people’s current reality we can build towards a greater impact in medical affairs

 𝐄𝐱𝐩𝐥𝐨𝐫𝐢𝐧𝐠 𝐭𝐡𝐞 𝐓𝐞𝐦𝐩𝐨𝐫𝐚𝐥 𝐃𝐢𝐬𝐭𝐫𝐢𝐛𝐮𝐭𝐢𝐨𝐧 𝐨𝐟 𝐏𝐡𝐚𝐬𝐞 𝟏 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐓𝐫𝐢𝐚𝐥𝐬 𝐀𝐜𝐫𝐨𝐬𝐬 𝐄𝐮𝐫𝐨𝐩𝐞 The last decade has witnessed intriguing trends in the registration of Phase 1 clinical trials across five key European countries: #France, #Germany, #Italy, #Spain, and the #UK. Data from ClinicalTrials.gov reveals fluctuating patterns, with the #UK leading in the number of registered #trials, while #Italy remains steady yet trailing behind its counterparts. Understanding these temporal distributions is crucial as they reflect the evolving landscape of early-stage clinical #research in #Europe, driven by #regulatory environments, #economic factors, and healthcare priorities. It's essential for #stakeholders to analyze these trends to foster #innovation and streamline processes across the region. Ref: https://lnkd.in/extSBR8m At #Mediception, we specialize in supporting #clinical research with tailored services that ensure compliance and #efficiency. Our #expertise helps navigate the complexities of clinical trials, allowing you to focus on advancing medical innovation. #ClinicalTrials #Phase1 #ClinicalResearch #Europe #Innovation #Healthcare #MediceptionServices

Great white paper summarising real-world data and medical affairs - the perfect combo 🤩 #Medcomms plays a pivotal role in devising the narratives that explain the relevance of RWD and shape future healthcare landscapes 💡 #medcomms #hiring #medicalaffairs #iqvia #medicalcommunications #medicalwriting #realworlddata #realworldevidence